ctrl K

Price Alert

Rocket Pharmaceuticals In... (RCKT)

NASDAQ: RCKT · Real-Time Price · USD

2.91

-0.12 (-3.96%)

At close: Aug 19, 2025, 3:59 PM

2.97

2.06%

After-hours: Aug 19, 2025, 07:54 PM EDT

Rocket Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	163.63M	55.9M	140.52M	232.69M
Short-Term Investments	208.7M	317.27M	215.88M	156.05M
Long-Term Investments	1.36M	34.32M	43.28M	1.34M
Other Long-Term Assets	529K	1.91M	1.95M	1.8M
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	5.85M	5.05M	7.67M	n/a
Total Current Assets	378.18M	378.22M	364.06M	392.06M
Property-Plant & Equipment	83.32M	87.59M	77.64M	72.35M
Goodwill & Intangibles	64.3M	64.3M	64.88M	30.82M
Total Long-Term Assets	149.52M	188.12M	187.75M	104.96M
Total Assets	527.7M	566.34M	551.81M	497.02M
Account Payables	1.63M	n/a	n/a	n/a
Deferred Revenue	n/a	n/a	-36.66M	-482
Short-Term Debt	n/a	2.72M	2.51M	2.55M
Other Current Liabilities	36.2M	7.21M	39.67M	11.93M
Total Current Liabilities	40.68M	48.51M	39.17M	22.17M
Long-Term Debt	n/a	22.33M	20.36M	20.05M
Other Long-Term Liabilities	1.14M	2.94M	2.6M	80K
Total Long-Term Liabilities	23.78M	25.26M	22.95M	20.13M
Total Liabilities	64.47M	73.77M	62.12M	42.3M
Total Debt	25.5M	25.04M	22.87M	22.6M
Common Stock	1.06M	903K	791K	645K
Retained Earnings	-1.22B	-959.37M	-713.77M	-491.91M
Comprehensive Income	66K	319K	-357K	-161K
Shareholders Equity	463.23M	492.57M	489.69M	454.72M
Total Investments	208.7M	351.59M	259.15M	156.05M